海外の治験の状況「脳卒中」での検索結果
122件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- A controlled, randomized, parallel, multi-centre, feasibility study of the oral direct thrombin inhibitor AZD0837, given as extended-release formulation, in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are appropriate for but unable or unwilling to take Vitamin-K antagonist therapy
- This is a phase II study to evaluate the feasibility of conducting a study in patients with AF who are appropriate for, but unable or unwilling to take VKA therapy. The intended indication for the product under development is the prevention of stroke and other thromboembolic complicationds associated with atrial fibrillation (AF) MedDRA version: 9.1 Level: LLT Classification code 10003658 Term: Atrial fibrillation
- Denmark, Sweden, United Kingdom
- 2007-05-16
Authorised
- Influence of a single dose of fluoxetine on brain activity during movement observation and execution, muscle activity and motor function in chronic stroke patients - Influence of fluoxetine on brain and muscle activity and motor function during movement (observation
- The objective of this study is to examine the effect of a single dose of fluoxetine and of movement observation on cortical activity in chronic stroke patients (>6 months after stroke). As secondary objectives, the effect of fluoxetine on motor function and muscle activity will be measured. MedDRA version: 9.1 Level: LLT Classification code 10055221 Term: Ischemic stroke
- Netherlands
- 2008-06-02
Authorised
- Study of efficacy, safety and tolerability of BAF312 compared to placebo in patients with stroke due to intracerebral hemorrhage (ICH)
- Intracerebral Hemorrhage MedDRA version: 20.1 Level: LLT Classification code 10022754 Term: Intracerebral hemorrhage System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Germany, Spain, United States
- 2017-12-14
Authorised
- STUDY OF THE EFFECTIVENESS OF THE COMBINED TREATMENT WITH DONEPEZILO, INTENSIVE REHABILITATION AND ELECTRIC STIMULATION OF THE BRAIN IN PATIENTS WITH AFASIA AFTER STROKE
- Chronic poststroke aphasia MedDRA version: 20.0 Level: PT Classification code 10002948 Term: Aphasia System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Spain
- 2018-08-02
Authorised
- NOR-SASS is a multi-centre PROBE (prospective randomised, open-label, blinded endpoint) trial, designed to establish the superiority of contrast-enhanced sonothrombolysis given within 4½ hours after stroke onset in consecutively admitted patients with acute ischaemic stroke, as compared with 1) standard iv thrombolysis with tenecteplase (TNK) or alteplase (tPA), and 2) no specific treatment in patients not eligible for thrombolytic treatment.
- All patients found eligible for thrombolysis may enter the thrombolysis-arm (NOR-SASS I), all patients with contraindications to thrombolysis within the 4 ½ hour time window may enter the no-thrombolysis-arm (NOR-SASS II). MedDRA version: 14.1 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Norway
- 2012-04-02
Authorised
- A randomized controlled trial of alteplase (rt-PA) vs standard treatment in acute ischemic hemispheric stroke in patients aged more than 80 years where thrombolysis is initiated within 3 hours after stroke onset - ND
- acute ischemic stroke br>MedDRA version: 9.1 Level: LLT Classification code 10043647 Term: Thrombotic stroke
- Italy
- 2008-02-08
Authorised
- A multi-centre exploratory study to evaluate the efficacy of the dopamine receptor agonist rotigotine in the treatment of hemispatial neglect and motor deficits following stroke. - A dopamine agonist for hemispatial neglect and motor deficits following stroke.
- Hemispatial neglect and motor deficits following right-hemisphere stroke. br>MedDRA version: 9.1 Level: LLT Classification code 10042244 Term: Stroke
- United Kingdom
- 2007-08-15
Authorised
- ‘Stem cell Trial of recovery EnhanceMent after Stroke 2’ (STEMS2) pilot randomised placebo-controlled trial of granulocyte-colony stimulating factor in mobilising bone marrow stem cells in sub-acute stroke. - STEMS2
- Ischaemic and Haemorrhagic Stroke br>MedDRA version: 8.1 Level: LLT Classification code 10042244 Term: Stroke
- United Kingdom
- 2007-01-26
Authorised
- Study to find out whether “Evacetrapib” can help patients who suffer from blockages in the blood vessels to their heart, brain, or legs who are at high risk for having a heart attack, stroke or may even die from the disease
- High Risk Vascular Disease (HRVD) MedDRA version: 18.1 Level: LLT Classification code 10067825 Term: Peripheral arterial disease System Organ Class: 100000004866 MedDRA version: 18.1 Level: PT Classification code 10051592 Term: Acute coronary syndrome System Organ Class: 10007541 - Cardiac disorders MedDRA version: 18.1 Level: PT Classification code 10011078 Term: Coronary artery disease System Organ Class: 10007541 - Cardiac disorders MedDRA version: 18.1 Level: LLT Classification code 10003602 Term: Atherosclerosis cerebral System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, France, Germany, Hong Kong, Hungary, India, Israel, Italy, Japan, Korea, Democratic People's Republic of, Lithuania, Mexico, Netherlands, New Zealand, Peru, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2012-07-17
Authorised
- Is it clinically effective to treat arm flexor spasticity, with Botulinum toxin – type A (BoNTA) and physiotherapy, as soon as signs of abnormal muscle activity are observed? (A phase II study) - Using BoNTA and physiotherapy to manage spasticity in acute stroke
- Stroke.Spasticity.
- United Kingdom
- 2011-06-27
